{
  "ticker": "GILD",
  "year": 2025,
  "quarter": 1,
  "last_updated": "2025-04-19T10:04:54.704574",
  "count": 44,
  "transactions": [
    {
      "id": 344098,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-03-17",
      "transaction_shares": "2500",
      "transaction_price": "110.53",
      "transaction_type": "S",
      "shares_after_transaction": "170674"
    },
    {
      "id": 391534,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-03-17",
      "transaction_shares": "2500",
      "transaction_price": "110.53",
      "transaction_type": "S",
      "shares_after_transaction": "170674"
    },
    {
      "id": 344077,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-03-10",
      "transaction_shares": "1952",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "40077"
    },
    {
      "id": 344079,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-03-10",
      "transaction_shares": "24024",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "641900"
    },
    {
      "id": 344106,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-03-10",
      "transaction_shares": "3343",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37692"
    },
    {
      "id": 344111,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "4916",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "173977"
    },
    {
      "id": 344151,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "8080",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "128059"
    },
    {
      "id": 391512,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-03-10",
      "transaction_shares": "1952",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "40077"
    },
    {
      "id": 391514,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-03-10",
      "transaction_shares": "24024",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "641900"
    },
    {
      "id": 391542,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-03-10",
      "transaction_shares": "3343",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "37692"
    },
    {
      "id": 391547,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "4916",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "173977"
    },
    {
      "id": 391587,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-03-10",
      "transaction_shares": "8080",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "128059"
    },
    {
      "id": 299150,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-18",
      "transaction_shares": "2500",
      "transaction_price": "104.09",
      "transaction_type": "S",
      "shares_after_transaction": "169061"
    },
    {
      "id": 344147,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-18",
      "transaction_shares": "2500",
      "transaction_price": "104.09",
      "transaction_type": "S",
      "shares_after_transaction": "169061"
    },
    {
      "id": 391583,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-18",
      "transaction_shares": "2500",
      "transaction_price": "104.09",
      "transaction_type": "S",
      "shares_after_transaction": "169061"
    },
    {
      "id": 299104,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "77691",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "248914"
    },
    {
      "id": 344099,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "77691",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "248914"
    },
    {
      "id": 391535,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-12",
      "transaction_shares": "77691",
      "transaction_price": "63.91",
      "transaction_type": "M",
      "shares_after_transaction": "248914"
    },
    {
      "id": 299108,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-02-04",
      "transaction_shares": "709",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37787"
    },
    {
      "id": 299114,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-02-04",
      "transaction_shares": "60031",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "561559"
    },
    {
      "id": 299130,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "94933"
    },
    {
      "id": 299138,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "149666"
    },
    {
      "id": 299155,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-02-04",
      "transaction_shares": "12371",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "34011"
    },
    {
      "id": 344103,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-02-04",
      "transaction_shares": "709",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37787"
    },
    {
      "id": 344110,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-02-04",
      "transaction_shares": "60031",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "561559"
    },
    {
      "id": 344127,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "94933"
    },
    {
      "id": 344135,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "149666"
    },
    {
      "id": 344153,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-02-04",
      "transaction_shares": "12371",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "34011"
    },
    {
      "id": 391539,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Patterson Sandra",
      "reporting_owner_cik": "0001968906",
      "reporting_owner_position": "SVP, Controllership",
      "transaction_date": "2025-02-04",
      "transaction_shares": "709",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "37787"
    },
    {
      "id": 391546,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "O'Day Daniel Patrick",
      "reporting_owner_cik": "0001638643",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2025-02-04",
      "transaction_shares": "60031",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "561559"
    },
    {
      "id": 391563,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Mercier Johanna",
      "reporting_owner_cik": "0001782135",
      "reporting_owner_position": "Chief Commercial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "94933"
    },
    {
      "id": 391571,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-02-04",
      "transaction_shares": "19793",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "149666"
    },
    {
      "id": 391589,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-02-04",
      "transaction_shares": "12371",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "34011"
    },
    {
      "id": 299103,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "26170",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156043"
    },
    {
      "id": 344097,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "26170",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156043"
    },
    {
      "id": 391533,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-31",
      "transaction_shares": "26170",
      "transaction_price": "57.92",
      "transaction_type": "M",
      "shares_after_transaction": "156043"
    },
    {
      "id": 258709,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-01-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21827"
    },
    {
      "id": 299128,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-01-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21827"
    },
    {
      "id": 344125,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-01-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21827"
    },
    {
      "id": 391561,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Telman Deborah H",
      "reporting_owner_cik": "0001860008",
      "reporting_owner_position": "EVP, Corporate Affairs & GC",
      "transaction_date": "2025-01-25",
      "transaction_shares": "515",
      "transaction_price": null,
      "transaction_type": "M",
      "shares_after_transaction": "21827"
    },
    {
      "id": 258714,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "2500",
      "transaction_price": "91.35",
      "transaction_type": "S",
      "shares_after_transaction": "129873"
    },
    {
      "id": 299134,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "2500",
      "transaction_price": "91.35",
      "transaction_type": "S",
      "shares_after_transaction": "129873"
    },
    {
      "id": 344131,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "2500",
      "transaction_price": "91.35",
      "transaction_type": "S",
      "shares_after_transaction": "129873"
    },
    {
      "id": 391567,
      "issuer_name": "GILEAD SCIENCES, INC.",
      "reporting_owner": "Dickinson Andrew D",
      "reporting_owner_cik": "0001310204",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2025-01-15",
      "transaction_shares": "2500",
      "transaction_price": "91.35",
      "transaction_type": "S",
      "shares_after_transaction": "129873"
    }
  ]
}